Cardiome Pharma Corp
Biotechnology - Vancouver, British Columbia, CA
Cardiome Pharma Corp Employees
Cardiome Pharma Corp Senior Management
Cardiome Pharma Corp Details
Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Patient Centered Research. We strive to find innovative medicines that provide value to patients, physicians and healthcare systems. We have two marketed products approved in Europe and other territories BrinavessTM (vernakalant IV), for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults and Aggrastat® a reversible GP IIb/IIIa inhibitor for use in Acute Coronary Syndrome patients. Investor Information Cardiome is traded on the NASDAQ Capital Market (CRME) and the Toronto Stock Exchange (COM).
Cardiome Pharma Corp Technologies
Email Providers
Outlook
Hosting
DigitalOcean